Europe Botulinum Toxin Market Size, Share & Industry Trends Analysis Report By Product, By Application (Therapeutic and Aesthetic), By End User (Hospitals, Dermatology Clinics and Spas & Cosmetic Centers, By Country and Growth Forecast, 2022 - 2028

The Europe Botulinum Toxin Market would witness market growth of 10.6% CAGR during the forecast period (2022-2028).

In order to inhibit the fusion of cholinergic vesicles with the cell membrane, the light (L) chain interacts with several proteins in the nerve terminals, including syntaxin, synaptosomal associated protein, or SNAP, and vesicle-associated membrane protein. After the injection, the paralytic effect peaks four to seven days later. Units of biological activity are the units used to express the dosage of all commercially produced botulinum toxins.

The computed median intraperitoneal lethal dose (LD50) for female Swiss-Webster mice is equal to one unit of botulinum toxin. The blocked neurotransmitter release is irreversible, yet the afflicted nerve terminals do not deteriorate. Nerve terminal sprouting and the development of new synaptic connections, which typically take two to three months, can restore function.

By preventing alpha motor neuron transmission at the neuromuscular junction, botulinum toxin causes striated muscle weakening. Its usage in disorders with excessive muscle activity, such as dystonia, is a result of this. Inhibiting transmission at gamma neurons within muscle spindles may change the overactivity of reflexes.

Acetylcholine is released at the presynaptic membrane of cholinergic neurons but is not released when the Clostridium botulinum toxin type A neurotoxin complex is present. In order to treat neuromuscular diseases, Botox was originally approved in the European Union by intramuscular injection. Botox for the treatment of axillary hyperhidrosis was proposed as a new indication through the Mutual Recognition Procedure (MRP) by the Marketing Authorization Holder, Allergan Pharmaceuticals (Ireland) Ltd.

The Germany market dominated the Europe Botulinum Toxin Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $708.9 Million by 2028.The UK market is anticipated to grow at a CAGR of 9.6% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 11.4% during (2022 - 2028).

Based on Product, the market is segmented into Type A and Type B. Based on Application, the market is segmented into Therapeutic and Aesthetic. Based on End User, the market is segmented into Hospitals, Dermatology Clinics and Spas & Cosmetic Centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Botulinum Toxin Market will Hit $10.5 Billion by 2028, at a CAGR of 10.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Evolus, Inc. (Alphaeon Corporation), Merz Pharma GmbH & Co. KGaA, AbbVie, Inc., Ipsen Pharma, Galderma S.A., USWM, LLC, and Metabiologics, Inc. (Object Pharma).

Scope of the Study

Market Segments Covered in the Report:

By Product

• Type A
• Type B

By Application

• Therapeutic
• Aesthetic

By End User

• Hospitals
• Dermatology Clinics
• Spas & Cosmetic Centers

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Evolus, Inc. (Alphaeon Corporation)
• Merz Pharma GmbH & Co. KGaA
• AbbVie, Inc.
• Ipsen Pharma
• Galderma S.A.
• USWM, LLC
• Metabiologics, Inc. (Object Pharma)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Botulinum Toxin Market, by Product
1.4.2 Europe Botulinum Toxin Market, by Application
1.4.3 Europe Botulinum Toxin Market, by End User
1.4.4 Europe Botulinum Toxin Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Botulinum Toxin Market

Chapter 4. Europe Botulinum Toxin Market by Product
4.1 Europe Type A Market by Country
4.2 Europe Type B Market by Country

Chapter 5. Europe Botulinum Toxin Market by Application
5.1 Europe Therapeutic Market by Country
5.2 Europe Aesthetic Market by Country

Chapter 6. Europe Botulinum Toxin Market by End User
6.1 Europe Hospitals Market by Country
6.2 Europe Dermatology Clinics Market by Country
6.3 Europe Spas & Cosmetic Centers Market by Country

Chapter 7. Europe Botulinum Toxin Market by Country
7.1 Germany Botulinum Toxin Market
7.1.1 Germany Botulinum Toxin Market by Product
7.1.2 Germany Botulinum Toxin Market by Application
7.1.3 Germany Botulinum Toxin Market by End User
7.2 UK Botulinum Toxin Market
7.2.1 UK Botulinum Toxin Market by Product
7.2.2 UK Botulinum Toxin Market by Application
7.2.3 UK Botulinum Toxin Market by End User
7.3 France Botulinum Toxin Market
7.3.1 France Botulinum Toxin Market by Product
7.3.2 France Botulinum Toxin Market by Application
7.3.3 France Botulinum Toxin Market by End User
7.4 Russia Botulinum Toxin Market
7.4.1 Russia Botulinum Toxin Market by Product
7.4.2 Russia Botulinum Toxin Market by Application
7.4.3 Russia Botulinum Toxin Market by End User
7.5 Spain Botulinum Toxin Market
7.5.1 Spain Botulinum Toxin Market by Product
7.5.2 Spain Botulinum Toxin Market by Application
7.5.3 Spain Botulinum Toxin Market by End User
7.6 Italy Botulinum Toxin Market
7.6.1 Italy Botulinum Toxin Market by Product
7.6.2 Italy Botulinum Toxin Market by Application
7.6.3 Italy Botulinum Toxin Market by End User
7.7 Rest of Europe Botulinum Toxin Market
7.7.1 Rest of Europe Botulinum Toxin Market by Product
7.7.2 Rest of Europe Botulinum Toxin Market by Application
7.7.3 Rest of Europe Botulinum Toxin Market by End User

Chapter 8. Company Profiles
8.1 Evolus, Inc. (Alphaeon Corporation)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Approvals and Trials:
8.2 Merz Pharma GmbH & Co. KGaA
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Approvals and Trials:
8.3 AbbVie, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.5.2 Approvals and Trials:
8.4 Ipsen Pharma
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 Galderma S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Geographical Expansions:
8.6 USWM, LLC
8.6.1 Company Overview
8.7 Metabiologics, Inc. (Object Pharma, Inc.)
8.7.1 Company Overview

TABLE 1 Europe Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 2 Europe Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 3 Europe Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 4 Europe Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 5 Europe Type A Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Type A Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Type B Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Type B Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 10 Europe Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 11 Europe Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Aesthetic Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Aesthetic Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 16 Europe Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 17 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Dermatology Clinics Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Dermatology Clinics Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Spas & Cosmetic Centers Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Spas & Cosmetic Centers Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Botulinum Toxin Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Botulinum Toxin Market by Country, 2022 - 2028, USD Million
TABLE 25 Germany Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 26 Germany Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 27 Germany Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 28 Germany Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 29 Germany Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 30 Germany Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 31 Germany Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 32 Germany Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 33 UK Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 34 UK Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 35 UK Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 36 UK Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 37 UK Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 38 UK Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 39 UK Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 40 UK Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 41 France Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 42 France Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 43 France Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 44 France Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 45 France Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 46 France Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 47 France Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 48 France Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 49 Russia Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 50 Russia Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 51 Russia Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 52 Russia Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 53 Russia Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 54 Russia Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 55 Russia Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 56 Russia Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 57 Spain Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 58 Spain Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 59 Spain Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 60 Spain Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 61 Spain Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 62 Spain Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 63 Spain Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 64 Spain Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 65 Italy Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 66 Italy Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 67 Italy Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 68 Italy Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 69 Italy Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 70 Italy Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 71 Italy Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 72 Italy Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 73 Rest of Europe Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 74 Rest of Europe Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 75 Rest of Europe Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 76 Rest of Europe Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 77 Rest of Europe Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 78 Rest of Europe Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 79 Rest of Europe Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 80 Rest of Europe Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 81 Key information – Evolus, Inc.
TABLE 82 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 83 Key information – AbbVie, Inc.
TABLE 84 Key Information – Ipsen Pharma
TABLE 85 Key Information – Galderma S.A.
TABLE 86 Key Information – USWM, LLC
TABLE 87 Key Information – Metabiologics, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: AbbVie, Inc.